Read's to-do list is already full

Just a few days into the reign of Pfizer's ($PFE) new chief executive Ian Read (photo), several events are creating challenges to the pharmaceutical giant's aim to quickly expand in fast-growing emerging markets--an area it is counting on to help offset the loss of its top-selling product. Report | Article